Trials / Conditions / Idiopathic Inflammatory Myopathy (IIM)

Idiopathic Inflammatory Myopathy (IIM)

10 registered clinical trials studyying Idiopathic Inflammatory Myopathy (IIM) — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases NCT06913608	Calibr, a division of Scripps Research	Phase 1
Not Yet Recruiting	OM336 in Seropositive Autoimmune Diseases NCT07229144	Ouro Medicines	Phase 1
Recruiting	GC012F Injection in Refractory Idiopathic Inflammatory Myopathy NCT07086404	Daishi Tian	EARLY_Phase 1
Not Yet Recruiting	GC012F in Patients With Autoimmune Diseases NCT07072884	Qiong Fu	EARLY_Phase 1
Recruiting	A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases NCT06980597	Beijing GoBroad Hospital	Phase 1
Recruiting	Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy NCT07150000	University of Bonn	—
Recruiting	Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases NCT06614270	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Recruiting	Safety Study of CC312 in Autoimmune Disease Patients NCT06888960	CytoCares Inc	EARLY_Phase 1
Recruiting	Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases NCT07085676	Polina Stepensky	Phase 1
Terminated	IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy NCT06462144	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	EARLY_Phase 1